期刊文献+

福安泰-03对高转移人卵巢癌细胞HO-8910PM侵袭能力的影响 被引量:4

Effect of Fuantai-03 on Invasion of Human Ovarian Cancer HO-8910PM Cells
下载PDF
导出
摘要 应用噻唑蓝法检测从赤魟中分离到的福安泰-03(Fuantai-03,FAT-03)对高转移人卵巢癌细胞HO-8910PM生长的影响;人工重组基底膜检测FAT-03对细胞侵袭能力的影响;SDS-聚丙烯酰胺凝胶电泳检测FAT-03对HO-8910PM细胞分泌MMP-9能力的影响。结果显示,FAT-03(20.0、40.0、60.0μg/ml)作用HO-8910PM细胞24h,对细胞生长的抑制率小于10%,对细胞与纤维粘连蛋白(fibronectin,FN)和Matrigel粘附的抑制率分别为15.1%、28.0%(P<0.05)、54.1%(P<0.01)和14.7%、34.3%(P<0.05)、40.5%(P<0.01),对细胞迁移的抑制率分别为16.4%、33.8%(P<0.05)和42.6%(P<0.01)。此外,FAT-03显著减少HO8910-PM细胞分泌MMP-9的量,并降低其活性。这些实验事实提示FAT-03能明显抑制HO-8910PM细胞的侵袭能力。 MTT assay was adapted to measure the effect of Fuantai-03 (FAT-03) isolated from Dasyatis akajei on the growth of human ovarian cancer HO-8910PM cells; artificial reconstituted basement membrane was utilized to evaluate the invasive activity; SDS-PAGE was employed to analyze the effects of FAT-03 on the activity and secretion of MMP-9 by HO-8910PM cells. The results showed that cell growth inhibition rates were 〈10% after the treatment of HO-8910PM with FAT-03 (20.0, 40.0, 60.0μg/ml) for 24 h, and that FAT-03 (20.0, 40.0, 60.0 μg/ ml) inhibited HO-8910PM cells to adhere to the basement membrane components FN and Matrigel by 15.1%, 28.0% (P〈0.05), 54.1% (P〈0.01), and 14.7%, 34.3% (P〈0.05), 40.5% (P〈0.01), respectively, and decreased the percentages of locomoting and migrating HO-8910PM cells by 16.4%, 33.8% (P〈0.05), 42.6% (P〈0.01), respectively. In addition, FAT-03 significantly inhibited the activity of MMP-9 and its secretion by HO-8910PM cells in a dosedependant manner. These experimental facts suggest that FAT-03 can significantly inhibit the invasion of HO- 8910PM cells.
出处 《细胞生物学杂志》 CAS CSCD 2009年第3期384-388,共5页 Chinese Journal of Cell Biology
基金 国家自然科学基金(No.30271493) 广东省自然科学基金重点项目(No.021386)资助~~
关键词 赤舡 福安泰-03 侵袭 MMP-9 高转移人卵巢癌细胞株(HO-8910PM细胞) Dasyatis akajei FAT-03 invasion MMP-9 HO-8910PM cells
  • 相关文献

参考文献25

二级参考文献110

共引文献117

同被引文献21

  • 1王金万,孙燕,刘永煜,于起涛,张沂平,李凯,朱允中,周清华,侯梅,管忠震,李维廉,庄武,王东林,梁后杰,秦凤展,卢辉山,刘晓晴,孙红,张燕军,王杰军,罗素霞,杨瑞合,涂远荣,王秀问,宋恕平,周静敏,游丽芬,王竞,姚晨.重组人血管内皮抑素联合NP方案治疗晚期NSCLC随机、双盲、对照、多中心Ⅲ期临床研究[J].中国肺癌杂志,2005,8(4):283-290. 被引量:625
  • 2薛文娇,范代娣,尚龙安,鱼奇鳞.离子交换批量层析纯化重组类人胶原蛋白Ⅱ[J].化学工程,2006,34(11):8-11. 被引量:3
  • 3Yu L, Zhang Y, Ma R, et al. Potent protection of ferulic acid against excitotoxie effects of maternal intragastric administration of monosodium glutamate at a late stage of pregnancy on developing mouse fetal brain [ J]. Eur Neuropsychopharmacol, 2006, 16 (3) :170-177.
  • 4Wang F, Ma R, Yu L. Role of mitochondria and mitoehondrial cytoehrome c in tubeimoside i-mediated apoptosis of human cervical carcinoma Hela cell line [ J ]. Cancer Chemother Pharmaeol, 2006, 57 ( 3 ) : 389-399.
  • 5Folkman J. Tumor angiogenesis: therapeutic implication [ J]. N Engl J Med, 1971, 285(21) : 1182-1186.
  • 6Folkman J. What is the evidence that tumors are angiogenesis dependent? [ J]. J Natl Cancer Inst, 1990, 82( 1 ) : 4-6.
  • 7Folkman J. Clinical applications of research on angiogenesis[ J]. N Engl J Med, 1995, 333(26) :1757-1763.
  • 8van Netten J P, Cann S A, van der Westhuizen N G, et al. Angiogenesis and tumor growth[J]. N Engl J Med, 1996, 334 (4) :920-921.
  • 9Folkman J. Role of angiogenesis in tumor growth and metastasis [J]. Semin Oncol 2002, 29(6 Suppl 16) :15-18.
  • 10O'Reilly M S, Boehm T, Shing Y, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth[ J], Cell, 1997, 88(2) : 277-285.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部